IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Publication Information:
      Spandidos Publications
    • Publication Date:
      2015
    • Abstract:
      Abstract. Inflammation is regarded as one of the major hallmarks of tumors, and has a very close relationship with gastric cancer. Interleukin-33 (IL-33), a new member of the IL-1 family, [...]
    • ISSN:
      1021-335X
    • Accession Number:
      10.3892/or.2015.3898
    • Rights:
      Copyright 2015 Gale, Cengage Learning. All rights reserved.
      COPYRIGHT 2015 Spandidos Publications
    • Accession Number:
      edsgcl.421083911
  • Citations
    • ABNT:
      YE, X.-L. et al. IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance. Oncology Reports, [s. l.], n. 6, p. 2746, 2015. DOI 10.3892/or.2015.3898. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsghw&AN=edsgcl.421083911. Acesso em: 31 mar. 2020.
    • AMA:
      Ye X-L, Zhao Y-R, Weng G-B, et al. IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance. Oncology Reports. 2015;(6):2746. doi:10.3892/or.2015.3898.
    • APA:
      Ye, X.-L., Zhao, Y.-R., Weng, G.-B., Chen, Y.-C., Wei, X.-N., Shao, J.-P., & Ji, H. (2015). IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance. Oncology Reports, 6, 2746. https://doi.org/10.3892/or.2015.3898
    • Chicago/Turabian: Author-Date:
      Ye, Xiao-Lei, Ya-Rong Zhao, Guo-Bin Weng, Yi-Chen Chen, Xue-Ni Wei, Jing-Ping Shao, and Hui Ji. 2015. “IL-33-Induced JNK Pathway Activation Confers Gastric Cancer Chemotherapy Resistance.” Oncology Reports, no. 6: 2746. doi:10.3892/or.2015.3898.
    • Harvard:
      Ye, X.-L. et al. (2015) ‘IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance’, Oncology Reports, (6), p. 2746. doi: 10.3892/or.2015.3898.
    • Harvard: Australian:
      Ye, X-L, Zhao, Y-R, Weng, G-B, Chen, Y-C, Wei, X-N, Shao, J-P & Ji, H 2015, ‘IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance’, Oncology Reports, no. 6, p. 2746, viewed 31 March 2020, .
    • MLA:
      Ye, Xiao-Lei, et al. “IL-33-Induced JNK Pathway Activation Confers Gastric Cancer Chemotherapy Resistance.” Oncology Reports, no. 6, 2015, p. 2746. EBSCOhost, doi:10.3892/or.2015.3898.
    • Chicago/Turabian: Humanities:
      Ye, Xiao-Lei, Ya-Rong Zhao, Guo-Bin Weng, Yi-Chen Chen, Xue-Ni Wei, Jing-Ping Shao, and Hui Ji. “IL-33-Induced JNK Pathway Activation Confers Gastric Cancer Chemotherapy Resistance.” Oncology Reports, no. 6 (2015): 2746. doi:10.3892/or.2015.3898.
    • Vancouver/ICMJE:
      Ye X-L, Zhao Y-R, Weng G-B, Chen Y-C, Wei X-N, Shao J-P, et al. IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance. Oncology Reports [Internet]. 2015 [cited 2020 Mar 31];(6):2746. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsghw&AN=edsgcl.421083911